Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

ClinicalTrials.gov ID: NCT03199963

Public ClinicalTrials.gov record NCT03199963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D

Study identification

NCT ID
NCT03199963
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
BHR Pharma, LLC
Industry
Enrollment
223 participants

Conditions and interventions

Interventions

  • 4-OH tamoxifen Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 20, 2017
Primary completion
Jan 13, 2019
Completion
Apr 22, 2019
Last update posted
Jul 25, 2022

2017 – 2019

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
Mesa Obstetricians and Gynecologists/Cactus Clinical Research Mesa Arizona 85209
Visions Clinical Research Tucson Arizona 85712
United Clinical Research Beverly Hills California 90211
City of Hope Duarte California 91010
USC-Keck Medical Center Los Angeles California 90033
South Florida Medical Research Aventura Florida 33180
Lake OB-GYN Associates of Mid-Florida Leesburg Florida 34748
Physician Care Clinical Research, LLC Sarasota Florida 34239
Affiliated Clinical Research, Inc. Las Vegas Nevada 89113
Center for Women's Health and Wellness Plainsboro New Jersey 08536
Bosque Women Care/Cactus Clinical Research Albuquerque New Mexico 87109
Carolina Women's Research and Wellness Center Durham North Carolina 27713
Aventiv Research, Inc. Columbus Ohio 43213
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464
University of Virginia Medical Park Northridge Charlottesville Virginia 22903
Overlake Internal Medicine Associates, PS Bellevue Washington 98004
Dedicated Women's Health Specialists Puyallup Washington 98372

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03199963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03199963 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →